Carregant...

The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than the clinic BP or daytime BP in hypertensive patients complicated by chronic kidney disease...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yanagi, Mai, Tamura, Kouichi, Fujikawa, Tetsuya, Wakui, Hiromichi, Kanaoka, Tomohiko, Ohsawa, Masato, Azushima, Kengo, Maeda, Akinobu, Kobori, Hiroyuki, Umemura, Satoshi
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594468/
https://ncbi.nlm.nih.gov/pubmed/23154587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!